Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study
Preexisting CMD and multimorbidity are significant risks for MACE among men treated for PC within the VA healthcare system whether treated with ADT + RT or with RT alone, highlighting the importance pretreatment optimization of comorbidities.
Authors
- Alexander R. Lucas (ORCID: https://orcid.org/0000-0001-7318-3387)
- Vanessa B. Sheppard (ORCID: https://orcid.org/0000-0003-2874-6659)
- Bassam Dahman (ORCID: https://orcid.org/0000-0001-7209-5369)
- Rhonda L. Bitting (ORCID: https://orcid.org/0000-0002-5253-0551)
- Asit K. Paul (ORCID: https://orcid.org/0000-0002-3517-4196)
- Bhaumik Patel (ORCID: https://orcid.org/0000-0001-8304-8509)
- Samina Hirani (ORCID: https://orcid.org/0000-0002-9607-9192)
- W. Gregory Hundley (ORCID: https://orcid.org/0000-0001-9947-6444)
- Michael G. Chang
- Dustin Bastiach
Institutions
- Duke University (US)
- Virginia Commonwealth University (US)
- University Health System (US)
- Hunter Holmes McGuire VA Medical Center (US)
- Virginia Commonwealth University Medical Center (US)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1186/s40959-025-00312-x
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- U.S. Department of Veterans Affairs
- Division of Cancer Prevention, National Cancer Institute
- National Heart, Lung, and Blood Institute